ClinVar Miner

Submissions for variant NM_000487.6(ARSA):c.979+1G>A

dbSNP: rs754722529
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000169323 SCV000220656 likely pathogenic Metachromatic leukodystrophy 2014-08-28 criteria provided, single submitter literature only
Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India RCV000169323 SCV002054026 pathogenic Metachromatic leukodystrophy criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000169323 SCV002295965 pathogenic Metachromatic leukodystrophy 2023-10-28 criteria provided, single submitter clinical testing This sequence change affects a donor splice site in intron 5 of the ARSA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ARSA are known to be pathogenic (PMID: 8962139, 10477432). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. Disruption of this splice site has been observed in individuals with metachromatic leukodystrophy (PMID: 14517960, 34276053, 34554397). This variant is also known as c.973+1G>A. ClinVar contains an entry for this variant (Variation ID: 188949). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
GeneDx RCV003151752 SCV003840880 pathogenic not provided 2023-03-13 criteria provided, single submitter clinical testing Reported as c.973+1 G>A and seen with a second ARSA variant, phase unknown, in a patient with juvenile MLD in the published literature (Eng et al., 2003); Canonical splice site variant predicted to result in a null allele in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34554397, 34276053, 14517960)
Myelin Disorders Clinic-Children's Medical Center/Medical Genetics Lab-Tarbiat Modares University, Children's Medical Center, Pediatrics Center of Excellence, RCV000169323 SCV001478468 likely pathogenic Metachromatic leukodystrophy no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.